Two-year recall for people with no diabetic retinopathy: a multiethnic population-based retrospective cohort study using real-world data to quantify the effect
暂无分享,去创建一个
A. Hingorani | P. Remagnino | R. Sofat | A. Warwick | Y. Wu | E. Chew | A. Rudnicka | A. Olvera-Barrios | A. Tufail | R. Welikala | J. Anderson | C. Owen | C. Egan | A. Lee | F. Ferris | J. Fajtl | L. Bolter | S. Barman | R. Chambers
[1] B. Duncan,et al. IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.
[2] A. Rudnicka,et al. Effect of ethnicity and other sociodemographic factors on attendance at diabetic eye screening: a 12-month retrospective cohort study , 2021, BMJ Open.
[3] James G. Lathe,et al. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT , 2020, Diabetologia.
[4] Stephen J. Aldington,et al. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients , 2020, British Journal of Ophthalmology.
[5] D. Owens,et al. Cost-effectiveness of biennial screening for diabetes related retinopathy in people with type 1 and type 2 diabetes compared to annual screening , 2020, The European Journal of Health Economics.
[6] Giri N. K. Rangan,et al. Committee , 2019, 2019 International Conference on Radar, Antenna, Microwave, Electronics, and Telecommunications (ICRAMET).
[7] L. Goff,et al. Ethnicity and Type 2 diabetes in the UK , 2019, Diabetic medicine : a journal of the British Diabetic Association.
[8] P. Scanlon. The English National Screening Programme for diabetic retinopathy 2003–2016 , 2017, Acta Diabetologica.
[9] K. Bhaskaran,et al. Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: a cohort study in the Clinical Practice Research Datalink 2004–2014 , 2017, BMJ Open.
[10] A. Rudnicka,et al. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness. , 2016, Health technology assessment.
[11] Catherine Egan,et al. Automated Diabetic Retinopathy Image Assessment Software: Diagnostic Accuracy and Cost-Effectiveness Compared with Human Graders. , 2016, Ophthalmology.
[12] Stephen J. Aldington,et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. , 2015, Health technology assessment.
[13] S. Taylor-Phillips,et al. Extending the diabetic retinopathy screening interval beyond 1 year: systematic review , 2015, British Journal of Ophthalmology.
[14] M. Bachmann,et al. Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals , 2014, Diabetes Care.
[15] D. Owens,et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service , 2014, British Journal of Ophthalmology.
[16] G. Roglić,et al. Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review , 2013, Diabetic medicine : a journal of the British Diabetic Association.
[17] Stephen J. Aldington,et al. A Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy , 2013, Diabetes Care.
[18] S. Sivaprasad,et al. Ethnic Variation in the Prevalence of Visual Impairment in People Attending Diabetic Retinopathy Screening in the United Kingdom (DRIVE UK) , 2012, PloS one.
[19] R Greenwood,et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales , 2003, Diabetic medicine : a journal of the British Diabetic Association.